Anniversary edition |transkript
|transkript began reporting on the life sciences industry in the DACH region 30 years ago. The current issue is dedicated to the magazine’s history, but above all highlights current topics. This time, the topics include obstacles to setting up a company, the absence of biotechnology in the new government’s coalition agreement, the latest developments in the organ-on-chip sector, the potential of breast milk in infection prevention and 3D tissue printing in regenerative medicine
Topics
- Foundation with obstacles – Lumatix Biotech GmbH
- Balancing interests – interview with Dr Christian Stein, Managing Director of Ascenion GmbH
The treasure chest is open – interview with Prof Dr Hartmut Juhl, CEO; Dr Matthias Evers, CBO, on the reorganisation of Hamburg-based Indivumed GmbH - Breast milk makes you healthy – Fraunhofer-IZI and the start-up Primogene examine the potential of breast milk in the prevention of infections
- Organs from the bioprinter – is the paradigm shift in regenerative medicine coming?
- Statistics: Swiss biotechnology sector stable
- Transcript in person – Dr Dominik Schumacher, CEO Tubulis GmbH
- Coalition agreement – tug-of-war over biotechnology
- Statement on bio-based resilience – Prof Dr Thomas Brück, Dr Markus Wolperdinger, Prof Dr Stefanie Heiden, Prof Dr Iris Lewandowski, Prof Dr Daniela Thrän
- Accelerated start of clinical trials delayed
- More targeted gene editing – new vector technology ENVLPE
- Catalym presents strategy against ADC drug resistance
- Promising Salmonella blocker
- Tracking Parkinson’s disease – Betasense GmbH finds biomarkers
- Scaling up, but the right way – interview with Frederieke Reiners, Vice-President New
|transcript special: Patent attorneys in the DACH region
Laborwelt special: Organoids and organ-on-chip
Focus on Medtech-zwo: automatica in Munich
Click here for the magazine.